The story of Sildenafil presents a interesting case for stakeholders in the medicinal sector. While initially a tremendous success, producing billions, the exclusivity end and the subsequent arrival of cheaper https://online-pharmacy556629.blog2news.com/42288934/the-little-copyright-and-the-pharmaceutical-industry-a-risky-investment